The product could hit the European market in late 2017
The Catalan biotechnology firm, valued at €95 millions, is preparing to be listed on the Spanish continuous market as a first step towards...
International experts analyze how to bring scientific advances to society in order to improve quality of life at CaixaForum Barcelona with...
Catalan pharmaceutical company Amgen has developed this drug, which is the second in a new class of inhibitors
More than 500 companies and a wide network of research centers and science parks, universities, hospitals and support agencies are the cluster of life sciences in Catalonia.